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Recently introduced computational metabolome mining tools have started to positively impact the
chemical and biological interpretation of untargeted metabolomics analyses. We believe that these
current advances make it possible to start decomposing complex metabolite mixtures into
substructure and chemical class information, thereby supporting pivotal tasks in metabolomics
analysis including metabolite annotation, the comparison of metabolic profiles, and network
analyses. In this review, we highlight and explain key tools and emerging strategies covering 2015
up to the end of 2020. The majority of these tools aim at processing and analyzing liquid
chromatography coupled to mass spectrometry fragmentation data. We start with defining what
substructures are, how they relate to molecular fingerprints, and how recognizing them helps to
decompose complex mixtures. We continue with chemical classes that are based on the presence
or absence of particular molecular scaffolds and/or functional groups and are thus intrinsically
related to substructures. We discuss novel tools to mine substructures, annotate chemical
compound classes, and create mass spectral networks from metabolomics data and demonstrate
them using two case studies. We also review and speculate about the opportunities that NMR
spectroscopy-based metabolome mining of complex metabolite mixtures offers to discover
substructures and chemical classes. Finally, we will describe the main benefits and limitations of the
current tools and strategies that rely on them, and our vision on how this exciting field can develop
toward repository-scale-sized metabolomics analyses. Complementary sources of structural
information from genomics analyses and well-curated taxonomic records are also discussed. Many
research fields such as natural products discovery, pharmacokinetic and drug metabolism studies,
and environmental metabolomics increasingly rely on untargeted metabolomics to gain
biochemical and biological insights. The here described technical advances will benefit all those
metabolomics disciplines by transforming spectral data into knowledge that can answer biological
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Complex metabolite mixtures are found everywhere in and
around us. Whether you study plant or microbial extracts,
environmental samples, or human urine or plasma, these
samples include vast numbers of chemically diverse molecules
whose structures are mostly unknown up to date.1,2 However,
such molecules can play important physiological, biochemical,
ecological, or diagnostic roles: in plants and microbes, they can
serve as messengers or as antibacterial or antifungal agents,
whereas in human biouids molecules can be signaling mole-
cules, biomarkers of disease, or markers of food intake or
microbial activity. In plants and microbes, we typically refer to
suchmolecules as natural products, or specializedmetabolites.3
Specialized metabolites were previously called secondary
metabolites, because they were thought not to be directly
involved with primary functions such as growth, reproduction,
or development, and they were assumed to be useless waste
products in early days. Instead, now they are known to have
advantageous effects on their producers in various “indirect”
ways, for example, by repelling herbivores thus preventing them
from eating the plant. Biosynthetic pathways for specialized
metabolites show great diversity at the level of taxa, organs, and
tissues;4–6 opposed to the central metabolism which is highly
conserved. Due to this reason, they are now known as special-
ized metabolites.
Knowing the structures and roles of all molecules in complex
mixtures would greatly enhance our knowledge of the ecologicalJustin J. J. van der Hoo is an
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associated metabolites and the food metabolome.
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View Article Onlinefunction of plants and microbes in the ecosystem. To better
tackle the chemical complexity of plants and microbes, analyt-
ical and computational approaches have been developed over
the last decade or two.7,8 More recently, the rst studies have
started to comprehensively analyze the specialized metabolome
through integrated analysis of tens to a few hundreds of
samples.9–11
Metabolomics is the eld of study that aims to get
a comprehensive view of the molecular contents of organisms.
Typical parts of a metabolomics study include sample collec-
tion, sample extraction, analytical measurement, data process-
ing and analysis, and biochemical interpretation.12 Mass
spectrometry (MS) and nuclear magnetic resonance (NMR)
spectroscopy are the analytical workhorses of metabolomics. A
major bottleneck in the metabolomics pipeline is metabolite
annotation and identication,13 i.e., the assignment of struc-
tures to spectral data. This is a critical step in metabolomics
workows as the assigned structures are key to biochemical
interpretation of the data. The classical route to characterizeFig. 1 Computational interpretation of NMR or MS data provides comp
entire structure can be identified directly, but more frequently we obtain
annotations and exemplify the information provided by each type of anno
docetaxel. Please note that we define analogues as metabolites that sha
related research mainly because they are reactant pairs or because th
Substructure annotations provide information on functional groups, build
give information on major backbone structures, which has been a major
estimates chemical similarity between analogues through spectral simila
on spectral data of multiple metabolites can provide insights on the biosyn
figure. We do note that docetaxel is a semisynthetic compound designe
Nat. Prod. Rep.specialized metabolites from complex metabolite mixtures is
through isolation and purication from the crude extract.14
First, the crude extract is separated into fractions using liquid
chromatography (LC). Oen, these fractions are further sepa-
rated into individual components with more subtle LC
approaches. The isolated and (semi-)puried molecules are
measured with MS, sometimes supplemented by MS fragmen-
tation (MS/MS), and extensive NMR measurements to collect
sufficient spectral information to solve the puzzles of howmany
atoms of which sort there are, and how they are connected to
each other. Thus, to come from the sample collection to
a couple of known structures can take weeks or months since it
is laborious work that involves analytical skills and chemical
expertise. It has become clear that to do large-scale mining of
the specialized metabolome, the classical reductive approach is
not suitable. Therefore, increasingly, untargeted metabolomics
approaches are employed that do a wide-screen survey of the
chemical diversity in samples and generate information-dense
high-resolution LC-MS/MS, or two dimensional (2D)-NMRlementary information related to chemical structures. Sometimes the
knowledge on partial structures only. Here, we define three types of
tation by using an example of two structural analogues: paclitaxel and
re the majority of their structures with each other, in natural products-
ey are a group of biosynthetically or chemically related metabolites.
ing blocks, or scaffolds within a chemical structure. Class annotations
criterion for chemical ontology of natural products. Network analysis
rity to form mass spectral networks. Structural annotations performed
thetic and chemical relationships between analytes as described in the
d based on the scaffold of paclitaxel.
This journal is © The Royal Society of Chemistry 2021
























































































View Article Onlineproles where interactions of neighboring protons or protons in
close proximity are recorded.14 Similarly, such a 2D-NMR
approach can be applied to protons and carbon atoms to
study their interactions and learn structural features of the
measured molecule. The two described analytical approaches
both aim to accurately cover as much as molecules that are
present in the complex mixtures, whereas also provide as much
structural information as possible through mass fragmentation
(MS/MS) spectra containing spectral patterns or NMR cross
peaks indicative for atomic connections. To facilitate the data
preprocessing, processing, analysis, and interpretation
numerous computational metabolomics tools have been intro-
duced.7 Whilst spectral databases containing reference spectra
are growing for both MS and NMR, the matching rates for
specialized metabolites to assign complete structures to spec-
tral data remain low.15 Therefore, we here argue that
substructure-based metabolomics workows offer anFig. 2 The structural annotation of plant flavone glycoside analogues
anticipation is highlighted. MetWork is a web application designed for sp
metabolite structures, and it will be further highlighted in Section 4.2.3. T
to be present in the plant extract. In these two structures, several features
bottom right corner, the main isoscutellarein motif could be assigned (m
acid and the glucose (neutral losses). The identification of these motifs
usingMetWork as can be seen in the displayed network. The cosine score
are displayed on the orange nodes. Altogether, the combined approac
glycosylated isoscutellarein analogues.
This journal is © The Royal Society of Chemistry 2021interesting and feasible alternative since they target smaller
parts of the molecules that are typically easier to structurally
annotate. Most specialized metabolites in complex metabolite
mixtures are not independent from each other: they can share
common substructures or can be part of the same biosynthetic
or biochemical pathway. Nature oen reuses the same building
blocks to create ever increasingly complex structures with
diverse functions. In metabolomics data, such building blocks
are expected to transpire into spectral patterns because groups
of atoms that are in a similar constitution and chemical envi-
ronment are likely to produce similar spectral signals. In other
words, basic building blocks such as saccharides and special-
ized metabolite scaffolds are expected to produce the same or
similar spectral signals even if they are present across different
complete structures. It is this hypothesis that most of the
currently available substructure discovery-based and chemical
class-based metabolomics workows use.by combining MS2LDA substructure finding and MetWork substance
ecialized metabolites anticipation using in silico metabolism to predict
he green nodes represent metabolites previously reported in literature
are clearly identified using theMass2Motif approach. As indicated in the
ass fragment ion in blue). Two other features are highlighted, the acetic
is in good agreement with the in silico metabolism products obtained
between experimental and theoretical spectra of anticipated analogues
h enables the confident assignment of 5 additional acylated and/or
Nat. Prod. Rep.
























































































View Article OnlineIn the following sections, we will highlight recently devel-
oped MS and NMR metabolite annotation tools that discover
substructure patterns in metabolomics data and provide ways
to annotate them and perform chemical compound class
annotations. In this review, we dene three different types of
structural annotations: substructure annotation, class annota-
tion, and network analysis (Fig. 1). Substructure annotation
provides information on functional groups, building blocks, or
scaffolds within a chemical structure, while chemical
compound class annotation gives information on major back-
bone structures based on the biosynthetic origin or historical
applications of the compounds – the latter has been a major
criterion for chemical ontology of natural products. Network
analysis does not provide structural information directly, but it
reveals relationships between molecules, such as chemical
similarity or shared substructures between metabolites, and it
can enhance the annotation and structural characterization of
multiple connectedmetabolites. We do note that the three types
of annotation we recognize here are not completely indepen-
dent of each other. For example, if a substructure annotation
provides the structural information that coincides with the
main scaffold, a chemical compound class annotation could be
provided on the basis of it. Furthermore, the coexistence of
substructure or chemical class features among multiple spectra
could be a foundation of network analysis. As the chemical
diversity of natural products is formed by the genetic diversity of
biosynthetic genes, all of the annotations also provide
biosynthesis-related information. Class annotation and
network analysis can reveal congeners biosynthesized through
a conserved upstream pathway, while substructure annotation
could inform on the diverse tailoring reactions. To accentuate
parts of the described workows, we use case studies on
monoterpene indole alkaloids and avone glycosides. We will
nish with our perspective on how substructure and network-
based analyses will transform future metabolomics workows
to make them more scalable, more reliable, and allow for
increased structural and functional interpretation of complex
metabolite mixtures.2 Substructure discovery-based MS-
based metabolomics tools
2.1 Substructures as building blocks of metabolites
In natural extracts, multiple metabolites typically share the
same or similar structural parts called substructures. The main
reason for this is that the metabolic complexity found in nature
is based on a nite number of molecular scaffolds that an
organism can produce and that it typically decorates with
various smaller (functional) groups. The instructions to
construct, link, and decorate these building blocks are
imprinted in the organism's genome. Hence, in complex
metabolite mixtures, most metabolites are structurally
somehow related to at least a few other metabolites through the
use of shared or similar biosynthetic machinery. The recogni-
tion of the building blocks of metabolomics directly from
spectral data is thus an attractive path to increase theNat. Prod. Rep.annotation power of metabolomics workows as they assist in
assigning structures to key parts of metabolites and group them
according to these annotations. Not only does this support
metabolite annotation workows that aim to solve complete
metabolite structures; it does provide additional benets: for
some biological questions, solving the complete structures may
not be necessary and using the structural information at the
substructure level may be sufficient. For example, comparative
metabolomics to link particular chemistry to a phenotype rather
than metabolite structures could be done based on differential
expression of substructure presence. The “old” way of spectral
interpretation in MS/MS-based metabolomics (manual inspec-
tion) was actually this type of annotation; because the key data
features of MS/MS, fragment ions and neutral losses, are
fundamentally related to substructures. In this section, we will
discuss recent machine learning-based tools that allow
researchers to extract substructure information in the form of
mass fragmentation patterns or molecular ngerprints from
mass spectrometry fragmentation proles. In some cases, this
information is also used for annotations of complete structures.2.2 Substructure discovery by MS2LDA
MS2LDA16 was developed for unsupervised substructure
discovery through the extraction of recurring spectral patterns,
termed Mass2Motifs, from mass spectrometry fragmentation
(MS/MS) spectra. It is inspired by the natural language pro-
cessing algorithm Latent Dirichlet Allocation (LDA),17 a method
developed to decompose text documents into a series of topics,
such as various categories for newspaper articles. This was
a deviation from the more traditional document clustering
techniques in that instead of attempting to place each docu-
ment into a single topic it allowed documents to be made up of
multiple topics. This resulted in the ability to decompose a set
of text documents into a smaller set of more meaningful topics
than would have been extracted with traditional document
clustering.
As described in the previous section, metabolites can oen
be considered to be built up from discrete building blocks or
substructures in much the same way that one can imagine
documents being built up from topics. By representing MS/MS
spectra in a bag-of-words formats (counts of the occurrence of
different fragment and neutral loss features), MS2LDA applies
an unsupervised LDA decomposition toMS/MS data resulting in
Mass2Motifs (topics) made up of small numbers of co-occurring
fragment and loss features. A single MS/MS spectrum can
include multiple Mass2Motifs, with a probability score
describing how much of the spectrum is made up of any
particular Mass2Motif directly provided from the unsupervised
LDA decomposition. An overlap score can also be computed
that describes how much of any particular Mass2Motif occurs
within a particular spectrum and, with the probability score, be
used as a threshold to associate spectra to Mass2Motifs.18
This decomposition can signicantly aid the structural
analysis of MS/MS data. Spectra can be grouped according to
shared Mass2Motifs and prevalence of Mass2Motifs can be
compared across different samples.18 Where many molecularThis journal is © The Royal Society of Chemistry 2021
























































































View Article Onlinespectra are hard to annotate directly based on library matching,
in silico annotation tools, or prediction of mass spectra from
structures, many Mass2Motifs can be annotated and these
annotations can be added to any spectrum that includes that
motif. For example, it was demonstrated that with fewer than 40
annotated Mass2Motifs a partial annotation of >70% of the
metabolite features in beer extracts could be made16 – showing
the promise of a substructure-based metabolomics approach.
Another use case is to start from the discovery of yet unknown or
unexpected substructures through their fragmentation patterns
that could lead to the characterization of novel metabolites: for
example, guided by MS2LDA analyses, the rst examples of
hybrid alkylated phenylpropane monoterpene indole alkaloids
were isolated from Callichilia inaequalis through the annotation
of a phenylpropane-related Mass2Motif.19 Furthermore, in
Fig. 2, it can be seen how MS2LDA could identify three main
features from the MS/MS spectra of these polyphenol metabo-
lites. The main Mass2Motif isoscutellarein is indeed present in
all the metabolites depicted on the gure, as well as the glucose
feature. The acetate is clearly identied on the acetylated
compounds resulting from the transformation of the
compounds on the bottom le corner, illustrating howMS2LDA
supports the metabolite annotation process and how MS2LDA
can discover Mass2Motifs that are directly related to (plant)
biosynthesis.
In the original MS2LDA pipeline, all Mass2Motifs need to be
annotated by researchers using expert knowledge or through
fragment-based searches in spectral libraries. Furthermore,
each analysis would learn a complete set of new Mass2Motifs.
However, the same Mass2Motifs will be rediscovered when
similar sample types are analysed, motivating the development
of an open database of structurally characterized Mass2Motifs
(MotifDB20) to which any user can add newly annotated
Mass2Motifs – known as MotifSets. Where a MotifSet was
measured from similar samples in the same ionization mode, it
can be included in a newMS2LDA analysis. MS2LDA will extract
these Mass2Motifs simultaneously with learning new Mass2-
Motifs, accelerating the annotation process by simultaneously
acknowledging known substructures and considering novel
chemistry. MS2LDA is available in the GNPS21 molecular
networking pipeline as well as through a dedicated web appli-
cation,22 at which MotifDB is currently also hosted.2.3 Substructure recommendation by MESSAR
A complementary approach to MS2LDA substructure discovery
is the MEtabolite SubStructure Auto-Recommender (MESSAR).
MESSAR was developed to recommend substructures that are
likely to be present in unlabeled (unannotated) MS/MS
spectra.23 This is inspired by recommendation services that
suggest purchases or services based upon individuals' previous
behaviour and choices. To train MESSAR in recognizing the
potential relationships between spectral features and
substructures, GNPS public spectral libraries21 were used. These
annotated spectra (with known molecular structure) were used
as reference spectra for establishing links between mass spec-
tral features (mass fragments, neutral losses, and massThis journal is © The Royal Society of Chemistry 2021differences) and substructures present in the molecules. The
latter are dened by determining the molecular ngerprints
present from the SMILES representations of the molecules,
resulting in vectors where the value in a particular position
indicates whether or not a particular substructure is present
(i.e., aromatic ring or nitrogen-containing 5-membered ring).
Then, rules are established to connect these substructures to
the mass spectral features derived from the MS/MS spectra,
thereby also using the hypothesis that the same substructure
produces the same or similar mass spectral features indepen-
dent of the other parts of the molecule that are connected to the
substructure.
The approach is inspired by the concept of association rule
mining (ARM) that discovers interesting relations based on
frequently co-occurring items. In the training process, a data-
base of 8378 mass spectral features to substructure rules was
established. To benchmark and validate their approach,
a comparison with MS2LDA was performed on the same set of
GNPS library spectra in which a number were previously vali-
dated using expert knowledge.16 A reliable overlap between the
8378 MESSSAR rules and 77 M2Ms (out of 500) was found, with
the annotations being identical or very similar to MESSAR
substructure recommendations for 26 out of 28 previously
validated Mass2Motifs. MESSAR is available as a web-based
tool. Overall, MESSAR and MS2LDA are complementary
approaches, since the rule-based approach and topic modelling
substructure discovery work differently: the learnt MESSAR
rules connect mass spectral features with specic substruc-
tures, while Mass2Motifs are spectral substructure patterns
derived from raw experimental spectra and can be learnt for
completely unknown chemistry as well, whereas MESSAR rules
need to be established on library spectra with known structures
and mass spectra. The authors also show strong orthogonality
between MESSAR, MS2LDA, and CSI:FingerID (discussed in the
next section) in terms of the substructure types these tools
accurately annotate: MESSAR performed best for polycyclic
aromatics, indoles, and chlorobenzenes, MS2LDA for sterones
and sugar conjugates, and CSI:FingerID for amino acids and
benzenesulfonyl amides. Given the complementary nature of
these approaches, we imagine that a meta-approach that inte-
grates their outputs could further increase substructure anno-
tation accuracy. The annotatedMotifSets fromMotifDB can also
be obtained through an Application Programming Interface
(API) and having a similar service available in the future for
MESSAR would further increase its options to integrate it into
existing and future pipelines. For example, this would allow
incorporating the most condent recommended substructures
into an annotation pipeline for automated Mass2Motif
substructure pattern annotations.2.4 Molecular ngerprint-based metabolite annotation by
CSI:FingerID
In silico annotation of MS/MS spectra with molecular structures
in the absence of reference spectra typically adopts one of two
core strategies. In the rst, spectra predicted from candidate
structures are compared with observed spectra.24,25 In theNat. Prod. Rep.
























































































View Article Onlinesecond, structural properties (normally molecular ngerprint
vectors) are predicted from the observed spectra and compared
with the same properties derived from candidate structures. Of
these, the latter approach has historically outperformed the
former.26 Of the ngerprint-based approaches, CSI:FingerID,
part of the SIRIUS soware package27 is the state-of-the-art.
CSI:FingerID starts with the computation of fragmentation
trees from the MS/MS spectra in which each mass fragment
becomes a tree node with the precursor ion as the tree origin
and the connections in the fragmentation tree representing
small chemical modications that are assumed to be part of
fragmentation pathways occurring in the collision cell of the
mass spectrometer. A number of connected and thus related
tree nodes typically represent a substructure of the fragmented
molecule. This approach has shown enormous gains in accurate
elemental formula assignments,27 and was recently com-
plemented with a network strategy to also gain improvements
for large molecules (>500 Da).28 The fragmentation tree forms
the input to a machine learning method for ngerprint
prediction. Here, CSI:FingerID makes use of a kernel method:
a class of machine learning methods that have been shown to
perform well across many domains. The Support Vector
Machine (SVM; see e.g.29) is the most popular kernel-based
classier, and is at the heart of CSI:FingerID. CSI:FingerID
uses multiple SVM classiers to predict, from the fragmentation
tree, the presence or absence of each of a set of several thousand
ngerprint elements resulting in a vector of the probabilities of
presence of each ngerprint element, i.e., the presence/absence
of an aromatic ring, presence/absence of a nitrogen atom, etc.
From compound databases, having their structures in hand, the
same ngerprint properties can be derived for the candidate
structures obtained; and therefore, these candidates can be
ranked according to the similarity of their ngerprint vectors
with that predicted from the query spectrum. A key feature of
SVMs in this context is that they do not explicitly use the frag-
mentation tree to make predictions, but rather the similarity
between pairs of trees. That enables the combination of
multiple similarity measures (via kernel functions) to allow for
the leverage of different representations of the input data.
Indeed, CSI:FingerID uses different types of structural infor-
mation derived from the computed fragmentation trees for its
predictions.3 Chemical class-based MS-based
metabolomics tools
3.1 Chemical classication of metabolomics features
The annotation of entire metabolite structures is very chal-
lenging and substructure-based strategies as described above
are thus an attractive route to decipher complex metabolite
mixtures. An alternative is to annotate metabolite features at the
chemical compound class level. Chemical compound classes
such as avonoids, polyketides, and peptides comprise many
different structures that do have some structural elements in
common. Many of these classes have been historically dened,
oen based on a combination of structural and functionalNat. Prod. Rep.properties. In that sense, chemical compound classes could be
regarded as a special variant of substructures where sometimes
multiple substructural features together with a specic biolog-
ical activity dene a compound class. For example, pharma-
ceutical activities (antivirals, antihypertensives) and the
biosynthetic origin (nucleic acids, terpenoids) have been used.
Over time, many classes have been split into subclasses as well;
for example, avonoid-3-O-glycosides is considered a subclass
of the avonoids. If all metabolite features measured in
complex metabolite mixtures could be annotated at such
chemical compound class or subclass levels, researchers would
be able to focus on a subset of metabolite features that belong to
the chemical class that they study, for example, or investigate
those that are likely to be completely novel. Indeed, for
a number of compound classes targeted or semi-targeted
approaches have been proposed, mostly based on the pres-
ence of specic mass spectral features in the mass fragmenta-
tion spectra; however, only since the last couple of years, various
approaches have been introduced that are able to link chemical
class annotation to large-scale metabolomics analyses. One key
element that enabled these developments was the introduction
of chemical ontologies, in particular those that can be directly
linked to and determined from textual representations of
metabolite structures. The latter allows computational work-
ows to classify candidate structures for mass spectral features
or to train machine learning models to recognize the links
between MS/MS spectra and chemical class terms, instead of
the manual inspection of the metabolite structures or usually
semi-automated extraction of key characteristic mass spectral
features from MS/MS spectra otherwise needed. Furthermore,
such a strategy can target the large variety of chemical struc-
tures that complex metabolite mixtures typically contain. In this
section, we will highlight important chemical ontologies and
currently available methods to perform large-scale chemical
compound class annotations as part of untargeted metab-
olomics workows.3.2 Chemical ontologies and taxonomies
3.2.1 ChEBI. Ontologies and taxonomies are of great value
across many scientic disciplines as they help scientists to
organize complex knowledge about concepts and to dene their
relationships. Taxonomies are schemes that establish hierar-
chical classication of concepts or objects. Ontologies share the
hierarchical structure of taxonomies, but oen allow for
multiple relationship types and they introduce a formal naming
of the types, properties and interrelationships of entities or
concepts. One of the rst extensive structural ontologies that
include chemical compound class annotations is part of the
Chemical Entities of Biological Interest (ChEBI) database.30 In
their Chemical Ontology, the molecular structure sub-ontology
classies molecular entities or parts thereof according to
elemental composition and structure, e.g., hydrocarbons,
carboxylic acids, or tertiary amines. This manually curated
ontology has the form of a directed acyclic graph with also some
cyclic relationships, thus meaning that a child term can have
many parents. For example, quercetin 3,40-di-O-b-D-glucosideThis journal is © The Royal Society of Chemistry 2021
























































































View Article Onlinehas many direct parent terms including monosaccharide
derivative, b-D-glucoside, polyphenol, and trihydroxyavone,
each describing a different aspect of the natural product in
a more generic or specic manner. One can follow these terms
all the way up toward “chemical entity”, for example, poly-
phenol – phenols – organic aromatic compound – aromatic
compound – etc. The LIPID MAPS comprehensive classication
system for lipids is worthmentioning here as well as an example
of such an ontology system focusing on lipid molecules.31
Whilst these ontologies have been applied successfully over the
years, the manual curation does make the classication and
annotation process quite tedious and sometimes inconsistent
whilst also requiring a lot of human expert knowledge.
3.2.2 ChemOnt & ClassyFire. To overcome the limitations
of the ChEBI molecular structure ontology and enable large-
scale automated chemical class annotations of molecular
structures, the ChemOnt ontology was introduced.32 ChemOnt
is ClassyFire's comprehensive chemical taxonomy currently
covering 4825 chemical classes of organic and inorganic
compounds to robustly characterize, classify and annotate
chemical structures. ClassyFire was the rst automated tool to
add chemical class annotations to candidate structures using as
input their textual representation (using SMILES33,34 or Inchi-
Keys33). Upon submission of a structure, ClassyFire returns
a hierarchical compound class annotation based on the pres-
ence and absence of particular substructures using the SMiles
ARbitrary Target Specication (SMARTS) format to detect them.
Assigned chemical taxa terms include many terms relevant for
natural product chemistry including triterpenoid, avonoid, or
hydrolysable tannin but also cover primary metabolites such as
those found in urine since the ChemOnt ontology primarily
serves generic metabolomics research. For example, ClassyFire
returns for quercetin 3,40-di-O-b-D-glucoside the following
terms: kingdom: organic compounds – superclass: phenyl-
propanoids and polyketides – class: avonoids – subclass:
avonoid glycosides – intermediate tree nodes: avonoid O-
glycosides – direct parent: avonoid-3-O-glycosides. In the
ChEBI ontology, comparable terms are part of the ontology tree
for this compound, whilst ClassyFire also contains terms like
phenolic glycosides as alternative direct parent; however, the
avonoid related path was deemed more relevant by ClassyFire.
With the continuous discovery of novel chemical structures, we
hope that the ChemOnt ontology and the associated classi-
cation rules will be extended and adapted over time to reect
new knowledge.
3.2.3 NPClassier. Although ClassyFire and CheBi paved
the way to automated class annotations of chemical structures,
not all natural products seemed to t in well in their classi-
cation systems. The most important reason is that natural
products typically have a slightly different criterion of classi-
cation than other chemicals. General chemical classication
systems classify each compound based on structural properties
(e.g., functional groups) of the compound itself; however, the
historical natural product classication system has mostly been
generated based on how the compound was generated in the
organismic system: the biosynthetic pathway. Thus, NPClassi-
er35 was proposed to link historical natural productThis journal is © The Royal Society of Chemistry 2021classications to structures using deep learning. NPClassier
converts the structure provided as a SMILES to a chemical
ngerprint, then classies it with a deep neural network model
built with 73 607 structures collected from public databases and
the three-level ontology system organized as 7 pathways, 70
superclasses, and 653 classes dened based on literature
search. Although this tool has been just introduced to the
community, it is expected to enhance a number of computa-
tional biology pipelines for linking genome and metabolome
datasets. Finally, it is presented as an open access tool to the
community and novel natural product compound classes can
easily be trained with sufficient available examples and added to
the classication scheme.
3.2.4 CANOPUS. The rst tools that build upon these
chemical ontologies have emerged. MolNetEnhancer36 uses the
ChemOnt ontology to provide a higher-level chemical overview
and is covered in Section 4.2.4. More recently, CANOPUS37 was
introduced which uses a deep neural network to predict 2497
ClassyFire compound classes from fragmentation spectra. This
workow does not depend on annotated candidate structures
but can assign compound classes directly to MS/MS spectra as
long as a fragmentation tree can be computed (see also Section
2.4 on CSI:FingerID). It is expected that NPClassier terms will
be added to CANOPUS in the near future.4 Network-based MS-based
metabolomics tools
4.1 Grouping metabolite features based on mass spectral
similarity
This section describes recent key tools that group mass frag-
mentation spectra based on their mass spectral similarity to
form networks of the fragmented metabolite features. Such
molecular networks or mass spectral networks help to logically
organize the large number of mass fragmentation spectra now
typically obtained within metabolomics experiments thus sup-
porting biochemical interpretations. Different approaches are
currently available to the metabolomics researcher and are
widely used by natural products researchers. Here, we highlight
and explain some of the currently most widely used ones as well
as some emerging tools that rely on input from molecular
networking. We use a case study of Monoterpene Indole Alka-
loids to show how mass spectral networking can aid in
biochemical interpretations but is also dependent on the mass
spectral similarity metrics and thresholds used to form the
network. The section ends with a brief overview of current tools
that allow networking analysis on gas chromatography (GC-)MS
datasets using electron impact ionization. This extends
networking-based analyses to volatile measurements, another
important group of molecules not covered by LC-MS metab-
olomics measurements.
4.1.1 Molecular networking. First introduced in 2012,38
molecular networking (or more generically called mass spectral
networking) has since become a popular tool in the analysis of
MS/MS-based metabolomics data.21,39 The theoretical rationale
of the method was quite straightforward. As fragmentationNat. Prod. Rep.
























































































View Article Onlinespectra acquired in MS/MS analyses are hypothesized to be
related to their original chemical structures, molecules with
similar structures will exhibit similar MS/MS spectra. Thus, if
we can calculate spectral similarities between all spectra within
a complex mixture, the spectral similarities can be extrapolated
to the structural similarities between molecules in the mixture.
The matrix of spectral similarity can be further visualized as
a graph called a spectral network or a molecular network, where
each node is a MS/MS spectrum, and edges between nodes
indicate spectral similarity above the similarity score threshold
dened by the user. The mass spectral similarity is calculated
with a modied cosine score. Each MS/MS spectrum is simpli-
ed as a vector in a multidimensional space where each
dimension corresponds to an m/z value of fragment ion and its
ion intensity. Then the angle between two spectral vectors in the
space is calculated to express the similarity between two
spectra. This is the cosine score, but Global Natural Products
Social (GNPS) molecular networking put a subtle modication
to the algorithm. Peaks from one spectrum are aligned with
peaks from the other either in their originalm/z position or with
theirm/z shied according to the difference in the precursorm/z
of the two molecules. The rationale behind this is that a single
modication to a structure will oen lead to a spectrum in
which a subset of the fragment peaks has shied by the m/z
shi of the modication (e.g., 18 Da for a water loss). The
theoretical background of the method may sound simple, but
its introduction caused a paradigm shi in the analysis of MS/
MS spectra. The beginning of a network analysis approach
means relationships between the spectra started to be consid-
ered, while each spectrum was analyzed independently in
conventional pipelines. By grouping spectra based upon their
similarity, molecular networking allows identifying so-called
molecular families corresponding to communities (or clus-
ters) in network theory.40 As molecular families are clusters of
molecules whose structures are expected to be similar to each
other, it gives multiple advantages to further metabolomics data
analysis. At rst, structural information on any molecular
family member could be propagated into other family
members. Network Annotation Propagation (NAP)41 automates
this process by exploiting this grouping to re-rank candidate
structure annotations from compound databases considering
the consistency of the structures within a molecular family: i.e.,
if 8 out of 10 nodes have a avonoid glycoside as top ranked
candidate, then the slightly lower ranked avonoid glycoside
structures for the two remaining nodes are more likely to be the
correct annotation than the top-1 ranked candidates that do not
have structural resemblance to avonoids (see also Section
4.2.2). For an extensive review of the various tools that have
been integrated within the GNPS platform in the context of
natural products research, we refer to Fox Ramos et al.39 Another
important advantage molecular networking provided to the
community is that it allowed chemically-informed comparative
analysis between samples. Multivariate methods conventionally
used in metabolomics treated every spectral feature as being
orthogonal to each other. However, as metabolites are products
of biological reactions, chemical relationships between each
molecule should be in consideration. Molecular networkingNat. Prod. Rep.allows such chemically informed sample-to-sample compar-
ison, even in cases where any spectral member of the molecular
family is not identied, as shown in development of the
chemical structural compositional similarity42 and Qemistree
which is further covered in Section 8.4.43
4.1.2 Alternative similarity scores and visualization for
mass spectral networks. As highlighted above, mass spectral
similarity is used as a proxy for structural similarity in MS/MS-
based network analysis. Although mismatches between spectral
similarity scores and the true structural similarities are
frequently observed, little development of alternative scores has
been undertaken. It is therefore very promising to see the recent
development of a novel mass spectral similarity score based on
an unsupervised machine learning approach inspired by the
natural language processing algorithm Word2Vec,44 called
Spec2Vec.45 Spec2Vec learns fragmental relationships within
a large set of spectral data to derive abstract spectral embeddings
that can be used to assess spectral similarities. Using data
derived from GNPS MS/MS libraries including spectra for nearly
13 000 unique molecules, it was demonstrated how Spec2Vec
scores correlate better with structural similarity than cosine-
based scores especially for structures that are not fully identical
but share most of their structural features. Consequently,
a higher accuracy was reported for library matching experiments.
Furthermore, the Spec2Vec score was used for mass spectral
network analysis as well as large-scale analogue search where
a large database is searched for structurally similar molecules
based on their MS/MS spectra without using any parent mass
ltering. To calculate the Spec2Vec scores, a mass spectral
embedding needs to be learnt once. Subsequent mapping of new
experimental MS/MS spectra on this embedding is then very fast.
As a consequence, Spec2Vec returns structural analogues found
in large databases within seconds, with particularly good results
for molecules in the higher mass range (400–2000 Da) as shown
for a GNPS library of >75 000 spectra with a cyclopeptide and
lipid example.45 We expect that Spec2Vec will trigger the emer-
gence of more novel machine learning-based mass spectral
similarity scores, both unsupervised and supervised, to further
improve its performance for a range of diverse tasks such as the
described library matching and analogue search, but for example
also adduct annotation and mass spectral network creation
tailored toward improved resolution for specic compound
classes. In fact, the rst example of a supervised machine
learning-based approach was just proposed.46 These develop-
ments may further assist in the biochemical interpretation of
such mass spectral networks thereby facilitating the process of
turning large-scale untargeted mass spectral analyses into
biochemical knowledge.
Olivon et al. developed MetGem,47 a soware by which molec-
ular networks can be generated based on two different algorithms:
cosine similarity between aligned spectra (the one used in the
GNPS molecular networking) and t-SNE (stochastic neighbour
embedding) algorithm, a well-known technique used for high-
dimensional data visualization.48 The t-SNE based graph does
position spectra due to local details within the entire data space,
which makes it possible to also draw conclusions about inter-
cluster relations (e.g., based on their distance) for closely relatedThis journal is © The Royal Society of Chemistry 2021
Fig. 3 Molecular networks of 23 monoterpene indole alkaloids generated using two different cosine score values (panels A and B) and two
different Spec2Vec threshold scores (panels C and D) and color-tagged according to different categories based on their manually curated
biosynthetic scaffolds with related scaffolds tagged in the same color. The seven representative skeletons are displayed with their names colored
according to these categories. (A) Molecular network created with a modified cosine score threshold of 0.7, displaying one molecular family
constituted by various skeletons and one singleton. (B) Molecular network of the same 23 nodes but at a modified cosine score threshold of 0.9,
featuring two homogeneous molecular families and six singletons. (C) Spec2Vec-based molecular network using a Spec2Vec score threshold of
0.6, displaying one molecular family constituted by various skeletons and two singletons. (D) Spec2Vec-based molecular network using
a Spec2Vec score threshold of 0.8, displaying three molecular families constituted by homogeneous skeletons and five singletons. We
demonstrate how the use of different mass spectral similarity metrics and score thresholds results in different network topologies and thus
influence the biochemical interpretability.
This journal is © The Royal Society of Chemistry 2021 Nat. Prod. Rep.

















































































































































































View Article Onlineclusters. It further allows clustering spectra without relying on
individual links between spectra and can thereby avoid the
tradeoff between having too many non-connected nodes or fusing
clusters which occurs when setting a similarity cutoff in molecular
networking. However, t-SNE does not provide information on the
relationships between individual spectra, which could then be
obtained by applying additional workows such as NAP annota-
tion and meta-mass shi analysis.49 Thus, the t-SNE-based visu-
alization and clustering is a method complementary to the cosine
similarity-based clustering.
4.1.3 Case study: molecular networking with monoterpene
indole alkaloids. Monoterpene Indole Alkaloids (MIAs) repre-
sent a complex structural family of more than 3000 (ref. 50)
compounds featuring an impressive array of structural variants
which are divided into 42 representative skeletons. In addition,
MIAs are also known for their various isomeric possibilities
leading to analytical intricacies with respect to their annotation.
To gain insight in how well network analyses reect the –
sometimes subtle–structural relationships of the MIAs, we
created modied cosine (as used in GNPS) and Spec2Vec-based
mass spectral networks. To illustrate the successes and the
limitations of network analysis, 23 selected MS/MS spectra
derived from the monoterpene indole alkaloid database
(MIADB)51 and belonging to seven representative skeletons
(Fig. 3), were subjected to the classical molecular networking
workow using two different modied cosine score thresholds
(Fig. 3A and B) and two different Spec2Vec thresholds (Fig. 3C
and D). For this case study, compounds belonging to the
yohimbinoid, corynanthean, and vallesiachotaman skeletons
are considered as structurally and biosynthetically related
scaffolds and were all color-tagged in blue, since they share the
same indole-quinolizidine sub-structure. The same reasoning
applies to the compounds pertaining to the ajmaline and sar-
pagine skeletons, as they share the bridgeheaded-indole–qui-
nolizidine motif. These two skeletons were coloured in purple.
As depicted in Fig. 3A, a modied cosine score threshold of 0.7
resulted in one seloop node in addition to one molecular
family that brought together six various MIA skeletons (i.e.,
iboga, yohimbinoid, corynanthean, vallesiachotaman, sarpa-
gine, aspidosperma, and ajmaline). With these parameter
settings and threshold, the singleton metabolite (19-acetylta-
bersonine), despite being related to the aspidosperma skeleton
(tagged in green), could not be linked to its three analogues,
namely, tabersonine, 16-hydroxytabersonine, and 19-hydrox-
ytabersonine. It is interesting to note that in the large molecular
family, the three distinct skeleton families are grouped
together, indicating that the network topology does reect to
some extent that these structures are more related to each other
than to other members of the molecular family. In Fig. 3B, we
observe how a higher threshold value led to the generation of
two molecular families of structurally similar compounds along
with six seloops. Satisfyingly, the four compounds related to
the sarpagine skeleton were linked together in this stricter
clustering. However, the four above mentioned aspidosperma-
related compounds were scattered as singletons. In both
cases, the iboga skeleton catharanthine (coloured in red), which
is present here as a sole representative, failed to be organized asNat. Prod. Rep.a singleton and, systematically, ends-up connected to yohim-
binoid, corynanthean and vallesiachotaman skeletons, despite
its apparent structural dissimilarity. In contrast, catharanthine
has been successfully depicted as a singleton in both Spec2Vec
networks (Fig. 3C and D). In addition, it is worth noting that the
yohimbinoid skeleton was nicely distinguished from the other
indole–quinolizidine-containing skeletons (i.e., corynanthean
and vallesiachotaman) (Fig. 3D). Altogether, this case-study
highlights the successes and the limitations of both spectral
similarity algorithms in linking apparently structurally similar
yet subtly different molecules from various biosynthetic origins.
This example also illustrates the difficulties in inferring struc-
tural similarity from mass spectral similarity. The observed
discrepancies could well stem from fragmentation rules
occurring in the gas phase that do not always allow us to
discriminate well based on the biosynthetic skeleton classi-
cation. A possible explanation is that in some cases minor
differences in the structure, i.e., the addition of a methyl or
hydroxyl group, can substantially change the preferred frag-
mentation paths leading to different diagnostic fragments of
the same skeleton. As such, it is promising to see the emergence
of Spec2Vec45 mass spectral similarity scores performing
complementary to the existing widely used cosine-based scores.
In the future, this may help us to nd alternative ways to link
the spectra of closely related terpene and alkaloid analogues
such as the MIAs studied here.
4.1.4 Molecular networking with electron impact (EI)
ionization MS data. Early efforts on networking analysis with
MS data were focused on electrospray ionization (ESI), which is
a common choice for hyphenation with HPLC. Electron Impact
(EI) MS, which is generally coupled to GC, is another important
domain of MS-based metabolomics that measures volatiles or
derivatized molecules that can also have important functions,
so efforts to establish molecular networking workows for EI
MS have started. The rst EI MS-based molecular network was
established with MetGem,52 together with MZmine2.53 In that
study, spectral deconvolution was performed using hierarchical
clustering in MZmine, then parent mass information was
removed from all the MS features; this processing allowed the
soware to build molecular networks based on only fragment
ions, not neutral losses. Approximately one year later, the GC-
MS-based molecular networking workow was introduced in
GNPS.54 The workow performs auto-deconvolution of
compound fragmentation patterns via unsupervised non-
negative matrix factorization, using a fast Fourier transform-
based strategy to overcome scalability limitations. A “balance
score” has been introduced in order to quantify the reproduc-
ibility of fragmentation patterns across all samples.4.2 Annotating the metabolite features in the network
4.2.1 Spectral library matching. The most common and
reliable method for metabolite annotation (where an MS2
spectrum is available) is through spectral library matching.
Here, observed spectra are compared against spectra stored in
reference libraries (e.g., MassBank, METLIN, GNPS, etc.). For
a particular observed query spectrum A, reference spectra areThis journal is © The Royal Society of Chemistry 2021
























































































View Article Onlinetypically rst ltered to only include those with a precursor m/z
sufficiently similar to that for A. The remaining spectra are then
scored against the query, most oen based upon some variant
of the cosine score (the inner (dot) product between two vectors,
normalized to lie between 1 and 1). As spectra don't naturally
lend themselves to points in a vector space, either them/z values
are binned and discretized into a xed length vector or an
alignment step is performed in which m/z peaks are matched
between the spectra. Because the intensity values in a spectrum
have to be positive, cosine scores for pairs of spectra should
always lie between 0 and 1.
Various variants on the cosine score are used. These differ by
(a) the ways in which the input spectral intensities are nor-
malised, (b) whether or not the m/z as well as intensity is
explicitly used in the calculation (e.g., to upweight contributions
for heavier (and therefore rarer) peaks). Forward and reverse
cosine scores can also be used which can be interpreted as
measuring how much of one spectrum exists in the other (i.e.,
how much query can be found in reference, or how much
reference can be found in query). Other variations include the
modied cosine (see Molecular networking section above) in
which fragment peaks can be shied by the m/z difference of
precursors, to account for simple chemical modications.
Although spectral search is the most popular and reliable
method for annotating metabolite features, challenges still
exist. The most pressing is the relatively small size of the
reference databases: only a very small subset of known chem-
icals are covered. In addition, although work has been done in
this area,55–58 there is still no widely used method for computing
false discovery rates for these data, which can make interpre-
tation of cosine scores highly subjective without extensive
manual inspection of spectral matches in terms of overlapping
peaks and their intensity patterns.
4.2.2 Structure libraries for structural annotation.
Although the number of mass spectra deposited in spectral
libraries are growing fast, it is still much less than the total
number of known chemicals. In silico fragmentation tools are
one of the solutions to overcome this limitation of spectral
library matching. By taking advantage of structural libraries,
computational fragmentation tools increase the annotation rate
in MS/MS-based metabolomics studies.2 Since metabolite
identication has been a bottleneck in untargeted metab-
olomics pipelines, various in silico tools have been developed:
CSI:FingerID59 and DEREPLICATOR+ (ref. 60) are recent
examples.
As molecular networking has risen as one of the major
methodologies in metabolomics, integration of in silico
methods with molecular networking has been explored. ISDB-
DNP is a hypothetical spectral database which was generated
by CFM-ID24 with structures from Dictionary of Natural Prod-
ucts;61 and it was successfully integrated with molecular
networking to provide metabolite annotations.62 More recently,
taxonomically informed scoring was suggested as a method for
enhancing the condence of annotation using ISDB-DNP for
natural product datasets.63 Network Annotation Propagation
(NAP) is the rst in silico annotation method which directly
exploits the network topology provided by molecularThis journal is © The Royal Society of Chemistry 2021networking.41,64 It re-ranks the candidate structures found by
MetFrag41,64 based on the expected consistency of annotations
within molecular families of connected components (see
Section 3.1).
4.2.3 MetWork. MetWork65 was designed as a tool for
specialized metabolite “anticipation”. The main idea of antici-
pation is that all the molecules of a metabolome are connected
by at least one chemical or biochemical transformation.66,67 It
represents an implementation of the virtuous circle of metab-
olite identication68 and is composed of three modules:
a participatory database containing the available chemical
transformations, a spectra prediction module based on CFM-
ID24 and a module for comparing predicted and experimental
spectra allowing the annotation of molecules. This web service
has been used in several studies leading to the identication of
new compounds using the logical link which are biosynthetic
transformations to locate and name interesting ions in the
extracts. The whole process of natural products anticipation has
been further formalized into the computer assisted natural
products anticipation (CANPA) approach,69 which is giving
more weight to the links between compounds that were previ-
ously reported. Following the CANPA approach, ve new sar-
pagine N-oxide alkaloids were discovered starting from known
sarpagine alkaloid structures that were in silico biotransformed
using reactions including, N-, and O-methylation, N-oxidation,
and para-indole hydroxylation known to occur for these alka-
loids. The new structures were isolated, and their postulated
structures could be veried with NMR. It is clear that this
approach relies on known structures to serve as known anchors
in the network, and a good dereplication pipeline is thus
mandatory for the proper functioning of the MetWork tool.
Altogether and following the computer assisted natural prod-
ucts anticipation (CANPA) approach, MetWork helps to move
from the collection of data and information toward the creation
of knowledge in the data, information, knowledge, and wisdom
(DIKW) pyramid.69
Case study: identication of avone glycosides from Sideritis
hyssopifolia. The combination of both MetWork and MS2LDA
for the annotation of several avone glycoside analogues from
the plant Sideritis hyssopifolia is shown in Fig. 2. Using the
compounds from the literature (green nodes) as an input for the
in silico metabolism gives rise to multiple putative compounds
using simple transformations such as ester hydrolysis or
methylation (blue rectangles). The prediction of MS/MS spectra
corresponding to the putative compounds is used as a threshold
to allow an annotation of the proposed structures. For this
specic class of compound, the comparison between theoretical
and experimental MS/MS spectra using the dot product metrics
provides good agreement (values > 0.58). Further conrmation
of the compound identication is given by MS2LDA. The
modications made through in silico metabolism are well
identied by the specic neutral losses and fragments on the
MS/MS spectra (bottom right corner in Fig. 2).
4.2.4 MolNetEnhancer. The multitude of mass spectral
metabolome mining and annotation tools and manifoldness of
different output formats and analysis platforms hamper the
easy visualization of output from complementary tools withinNat. Prod. Rep.
























































































View Article Onlineone data le or platform. This realisation has driven the
development of MolNetEnhancer.36 MolNetEnhancer is a work-
ow that combines the output from spectral library matching
and in silico structural annotation onto a GNPS mass spectral
molecular network. In this way it not only facilitates analysis,
but also allows for powerful visualizations of the chemical
diversity in the dataset. Chemical class annotation takes place
by calculating the most predominant chemical classes retrieved
for all top candidate matches per molecular family at each
hierarchical level of the ClassyFire chemical ontology onto the
network. Finally, substructure motifs (Mass2Motifs) learnt by
MS2LDA that are shared between mass features of the same
molecular family are visualized through additional edges con-
necting the nodes. Thus, instead of comparing tables and
output from multiple platforms, information from mass spec-
tral molecular networking, in silico structure annotation and
substructure discovery can easily be visualized within one
datale in Cytoscape.70 This allows researchers to investigate
and strengthen structural hypotheses by collecting information
from several complementary metabolome mining tools.
Recently, MolNetEnhancer was used to demonstrate that
sesquiterpene lactones, avonoids, fatty acids, and fatty acid
amides of various chicory (Cichorium intybus L.) cultivars dis-
played bioactivity against the parasitic helminth Ascaris suum.71
Furthermore, the workow was used to assess the wide range of
natural products of the lamentous fungus Paecilomyces sp.
CMAA1686 isolated from a cemetery in Brazil, which includes
pharmacologically active scorpionicidal (against Tityus serrula-
tus) terpene lactones, phenylpropanoids, and alkaloids.72 Mol-
NetEnhancer can conveniently be run through the GNPS
platform,21 currently supporting in silico structural input from
DEREPLICATOR,73 a tool to annotate peptidic natural products,
and Network Annotation Propagation.41 In the future, it is
anticipated that the output of other metabolite annotation tools
such as DEREPLICATOR+,60 which annotates besides peptides
also other compound classes such as polyketides and avo-
noids, and CANOPUS37 will also be compatible with the Mol-
NetEnhancer workow.
5 Substructure discovery by NMR
The latest developments in nuclear magnetic resonance (NMR)
spectroscopy experimentation and instrumentation have led to
a signicant increase in the use of NMR-based metabolomics
for the dereplication of natural products.14 Recently, several
innovative 1D NMR-based tools have emerged such as Mix-
ONat74 and CARAMEL,75 just to name a few; however, the
identication of compounds within complex mixtures using
NMR spectroscopy is still challenging mainly due to NMR signal
overlap that masks lower abundance signals and distorts signal
patterns and their quantitative areas.74–76 As a way to overcome
these resolution issues, deconvolution of signals has been
considered to be an essential step for NMR-based identication
of metabolites in complex mixtures. As such, Diffusion Ordered
SpectroscopY (DOSY)77 and Statistical TOtal Correlation Spec-
troscopY (STOCSY)78 are key methods for spectral deconvolu-
tion in NMR-based metabolomics. DOSY utilizes diffusionNat. Prod. Rep.coefficients of molecules, while STOCSY calculates correlation
coefficients between all the resonances across the entire
mixture data. Since the rst introduction of STOCSY, several
adaptations have been proposed to improve its performance:
such as Peak Overlap Detection by Clustering Analysis and
Sorting of Traces (POD-CAST)79 and COrrelation COmparison
Analysis for Peak Overlap Detection (COCOA-POD).80 Mean-
while, another approach for NMR spectral deconvolution using
13C–13C NMR correlation spectrum and indirect covariance
eigendecomposition was introduced recently, which success-
fully deconvoluted 13C spectra of rotenone and brucine from the
spectrum of their mixture as a benchmark.81 However, all of
these methods only deconvolute the complex spectra; manual
interpretation of NMR spectra is still required to identify the
chemical structures. Compared to MS, only a few automated
NMR-based tools have been developed for substructure
discovery from complex mixtures. Yet, some recently developed
technologies, dedicated to the structural recognition of mole-
cules, can be exploited to recognize partial spectral features that
correspond to substructures in the measured molecules. In the
following sections, different ways of detecting substructures by
NMR will be outlined (Fig. 4). The rst one will describe the
approaches that enable substructure assignment starting from
spectral features, the second will describe the tools that link
substructure ngerprints to their function (i.e., biological data),
whereas the last one will present the tools that allow to detect
spectral features that can be linked to unusual (and oen
previously unseen) substructures.5.1 Linking spectral features to substructures
5.1.1 dqfCOSY: generation of partial-structures from
crosspeaks and pattern recognition. Double-quantum-ltered
correlation spectroscopy is particularly suitable for the anal-
ysis of complex small-molecule mixtures because it displays
detailed coupling constant information, and oen permits clear
recognition of long-range 1H–1H-couplings, and displays easily
modeled cross-peak patterns that frequently enable interpreta-
tion of overlapping signals. Schroeder et al. used high-
resolution dqfCOSY to screen a library of bio-rationally
selected insect extracts to manually generate libraries of struc-
tural fragments (“partial structures”)82 based on spin system
connectivity. Further analysis of the data obtained of secretions
from pupal Delphastus catalinae data revealed a large group of
polyketide-like fragments. Satisfyingly, the subsequent data-
base searches for these motifs and associated NMR-
spectroscopic data indicated that these compounds were
unprecedented in nature. Based on this observation, this insect
was selected for further study and this led to the discovery of
catalipyrones, ten effective insect-repellent polyketides
featuring an unusual 23-carbon skeleton.
5.1.2 HMBC barcoding. Pauli et al. developed an innovative
concept of 2D-NMR barcoding that uses clusters of ngerprint
signals and their spatial relationships in the dH–dC coordinate
space to facilitate the chemical identication of complex
mixtures.83 The structural information of individual compounds
is encoded as a specic pattern of their carbon–protonThis journal is © The Royal Society of Chemistry 2021
Fig. 4 An overview of existing manual and automated 1D-NMR and 2D-NMR concepts for chemical classification and/or substructure finding.
The top panel shows how pattern recognition ((A) see 5.1.1, (C) see 5.1.4, (D) see 5.1.2, (E) see 5.1.3) and machine learning approaches ((B) see
5.1.5) allow to extract NMR spectral features that are linked to substructures. Automated workflows start to emerge for the various types of 2D-
NMR experiments; thus, manual input and validation remains important as 2D-NMR peak picking can still be tricky and challenging and is thus
often a manual task. To prioritize NMR spectral features in complex datasets for further analyses and elucidation, methods to link them to
bioactivity (panel at lower left: (F) see 5.2.1, and (G) see 5.2.2) and to assign them a novelty score (panel at lower right: (H) see 5.3.1 and (I) see 5.3.2)
are also emerging. We expect that with the increase in available NMR data and computational metabolomics approaches, the above-shown
concepts will further mature to come to (nearly) fully automated pipelines for NMR-based substructure and chemical class assignments.
























































































View Article Onlinecorrelation signals. Soware-based recognition of these patterns
enables the structural identication of the compounds and their
discrimination inmixtures. This approach was applied to explore
the triterpenes from various Actaea (syn. Cimicifuga) species as
a test case. Heteronuclear multiple-bond correlation (HMBC)
barcodes were generated on the basis of their structural subtypes
from a statistical investigation of their dH and dC data in the
literature. These reference barcodes allowed in silico identica-
tion of known triterpenes in enriched fractions obtained from an
extract of A. racemosa. Aer dereplication, a differential analysis
of heteronuclear single-quantum correlation (HSQC) spectra
even allowed for the discovery of a new triterpene. The 2D bar-
coding concept allowed for the rapid dereplication of known
compounds as well as the search for structural novelty.
5.1.3 HMBC networking. Hubert et al. developed an
elegant strategy featuring the networking theory for the
exploitation of heteronuclear 2D NMR data in the context of
natural crude extracts analysis.84 This in silicomethod leverages
HMBC and HSQC spectra to extract short-range and long-range
H–C correlations occurring in a carbon skeleton.This journal is © The Royal Society of Chemistry 2021Briey, an algorithm based on the community detection
recovers individualized HMBC ngerprints from theHMBC data of
a complex mixture. Then, the collected H–C correlations are rep-
resented as a network of NMR peaks. Aer the generation of
clusters from the obtained NMR peak network, molecular struc-
tures are assigned by means of an in-house theoretical HMBC and
HSQC correlation database. Although this strategy has been
exemplied for the identication of entire molecules, one can
imagine the application of this technique to link the HMBC
networking spectral features to substructures following a similar
strategy but now linking the clusters to partial structures for
example based on highly interlinked proton and carbon atoms.
5.1.4 Backbone topology determination. The Brüschweiler
lab developed an elegant approach85 based on a combination of
a 13C 2D-NMR technique (long time mixing time 13C CT-TOCSY)
and a deconvolution algorithm (DeCoDeC86) that will identify
traces that are unique for individual mixture components.
Interestingly, the carbon connectivity information will be
reconstructed from the assembly of each consensus trace using
short mixing time CT-TOCSY and COSY.87 This strategy wasNat. Prod. Rep.
























































































View Article Onlineapplied to the characterization of the metabolites of 13C-
enriched lysate of E. coli cells leading to determine their
carbon backbone topologies coined as “the topolome”. The
latter was dominated by carbon topologies of carbohydrates
(34.8%) and amino acids (45.5%) that can act as a foundation to
assemble more complex metabolites.
5.1.5 SMART. 1H–13C heteronuclear single quantum corre-
lation (HSQC) spectra, which provide correlations between
a carbon and its attached protons, are key data for structural
elucidation of chemical compounds. Small molecule accurate
recognition technology (SMART), of which the prototype was
introduced in 2017,88 is a deep convolutional neural network
(CNN)-based tool for automated annotation of compounds from
HSQC spectra. SMART takes a HSQC spectrum as an input and
gives a list of estimated compound structures based on a (deep)
CNN model trained with multiple HSQC spectra (2054 for the
prototype and 53 076 for version 2.0) of previously reported natural
molecules. In 2020, the rst application of SMART 2.0 for amixture
analysis was reported.89 In this work, SMART successfully esti-
mated that the active fraction of Symploca sp. extract would contain
a macrolide compound similar to swinholide; and the major
swinholide class molecule, symplocolide A, was subsequently iso-
lated and structurally determined from this fraction.5.2 Linking spectral features to bioactive substructure
ngerprint: pharmacophoric deconvolution
A continual quest of bioactivity-guided natural product
discovery workows lies in the development of key methods for
connecting small molecule structures with their biological
functions. In this regard, an interesting approach based on
statistical HeteroCovariance Analysis (HetCA) has been intro-
duced.90 Furthermore, several studies have shown that differ-
ential analyses of 2D NMR spectra (DANS) of natural product
extracts can be highly effective for associating small molecules
with specic biological properties.91 It is worth noting that, as is
true for all unsupervised methods developed for MS and NMR,
the exploitation of the NMR spectral data still relies on manual
interpretation with human expert knowledge.
5.2.1 ELINA: bioactivity correlation of NMR signals.
Grienke et al. developed ELINA (Eliciting Nature's Activities),
a strategy based on statistical heterocovariance analysis (HetCA)
of 1H NMR spectra detecting spectral features that are positively
(“hot”) or negatively (“cold”) correlated with bioactivity prior to
any isolation.92 ELINA is demonstrated with the discovery of
steroid sulfatase inhibiting lanostane triterpenes from
a complex extract of the polypore fungus Fomitopsis pinicola. As
a way to extract the spectroscopic signals related to the “hot”
features, STOCSY analysis was performed to generate the
ngerprint of the active component in the mixture. Indeed, the
ELINA approach efficiently extracts the spectral ngerprint of
the bioactive component from the data.
5.2.2 Plasmodesma: automatised pharmacophoric decon-
volution. To face the avalanche of data that derives from the
manual comparison of metabolomics studies or natural extracts
screening, Delsuc et al. developed a computer program, nick-
named Plasmodesma93 allowing the autonomous,Nat. Prod. Rep.unsupervised processing of a large corpus of 1D and 2D NMR
spectra acquired in different conditions. The capabilities of this
tool were extended to be able to extract the spectral ngerprint
of a molecule of interest from a set of NMR experiments
through a simple linear regression, leading to pharmacophoric
deconvolution.94 Briey, this tool (available at: https://
plasmodesma.igbmc.science) handles the NMR data as statis-
tical entities, and uses curated bucket lists rather than peak lists
for detecting signal variations which correlate with the activity.
Next, the results are displayed in an interactive visualization
manner in which an NMR spectroscopist should be able to
easily recognize molecular patterns.5.3 Linking spectral features to unusual substructures
5.3.1 MADByTE.MADByTE, which stands for Metabolomics
And Dereplication By Two-dimensional Experiments, is a compu-
tational tool for comparative analysis of NMR spectra from large
sample sets.95 It uses data acquired by two different NMR experi-
ments: 1H–13C HSQC and 1H–1H total correlation spectroscopy
(TOCSY). TOCSY can provide information on spin system features,
which is related to specic substructures of molecules; and MAD-
ByTE constructs an association network between spin system
features and samples, which can be pure compounds, fractions, or
extracts. From this, users can distinguish shared spin systems
between samples and use the information for dereplication and
recognition of unusual spin systems that are likely to belong to yet
unseen chemical substructures.
5.3.2 Atomic novelty scoring. Another 1H–13C HSQC
experiment-based method was suggested by Duggan et al. in
2019.96 The authors established a 1H–13C HSQC database using
publicly available spectra in the Human Metabolome Database
(HMDB)97 and the BioMagResBank.98 As a result, the authors
enlisted 10 308 1H–13C HSQC peaks from 1207 spectra. These
peaks were supposed to be common or usual peaks in general
molecules. Then, the authors calculated Euclidean distances
between all peaks in the proled spectrum (of single compound
or crude extract) to the closest peak in the database. Since the
1H or 13C chemical shis represent the chemical environment
of each atom in a molecule, this method can estimate the
novelty of each atom of molecules; thus, this method can be
used to prioritize a sample of interest or a target compound,
which is expected to contain a novel substructure.6 Toward NMR-based compound
class prediction through CASE
In mass spectrometry approaches, recent computational
advances have created several tools that allow to annotate
metabolomics proles with substructures (Section 2) and
chemical classes (Section 3). With the amazing improvements
in molecular structure recognition using NMR prediction tools,
ne determination of metabolite structure is enabled using the
modern approach of numerical chemistry. Recent advances in
soware packages that are used in computer assisted structure
elucidation (CASE) have minimized the prediction of 1H and 13C
signals to a precision of 1.2 ppm mol RMSE for 13C and 0.4This journal is © The Royal Society of Chemistry 2021
























































































View Article Onlineppm mol RMSE for 1H shis.99 This allows for NMR-based
metabolomics computational tools to start recognizing
substructures in complex metabolite mixtures, especially from
2D-NMR experiments (Fig. 4). This raises the question whether
NMR-based chemical compound class predictions will be
possible as well. So far, no dedicated and comprehensive tool to
do this akin to MolNetEnhancer or CANOPUS for mass spec-
trometry data has been proposed, but some early and recent
examples of successful approaches for 13C-based automated
chemical compound classication were introduced, i.e.,
CARAMEL,75 SENECA,100 and an approach based on a XGBoost
classier,101 as well as functional group recognition.102 For
example, the XGBoost classier performed well in the auto-
mated recognition of nine natural product classes yielding
performances above 80% accuracy for most classes on test data:
sesquiterpenoids, triterpenoids, and avonoids could be
distinguished well. Furthermore, the presence of a glycoside
moiety could be accurately predicted as well. We do note that
13C-NMR chemical shis are indeed well predicted using
quantum mechanics (Hartree–Fock [HF] or density functional
theory [DFT]) or machine learning (hierarchical organization of
spherical environments [HOSE]).103 The (further) automation
and extension of the above-mentioned workows, in particular
toward the use of 2D-NMR spectra, is hampered by the chal-
lenging process of 2D-NMR peak picking: existing methods are
indeed based on the intensities or the area of the NMR peaks
and oen fail in identifying peaks with low intensity or over-
lapping ones.104 Here, we expect that the development of
machine learning enhanced spectral feature recognition, for
example based on computer vision (SCRV),105 may play an
important role in automated 1H and 13C NMR data extraction
from experimental data, but also from NMR data presented in
literature to further expand spectral databases.
Next to improved spectral feature recognition that will boost
automated workows, we recognize a number of steps that the
eld could take and work on to further this area. Firstly, the
extension of NMR spectral libraries such as NMRShiDB106 will
help to map NMR signals to structures and their substructures
and molecular ngerprints. The latter two can be used for
automated chemical compound classication using ontologies
such as ChemOnt (from ClassyFire) or NPClassier. Such
extensions could also be done in silico107 where the predictions
are based on machine learning and incorporate an uncertainty
measurement. When incorporated into NMR databases, data
mining strategies could be used to link experimental and
condently predicted NMR shi signals and patterns to chem-
ical compound classes. This could also result in augmented
spectral databases and recently the PNMRNP database derived
from UNPD was introduced to the community of natural
product chemists.108 In a similar spirit, the chemical shi
prediction and matching capabilities of NMRlter at the
structural level could be extended to the substructure level.109 A
related KnapsackSearch was also introduced as a database
generator that provides taxonomically focused libraries of
metabolites to narrow down the search space in a “bio-logical”
manner. The importance of taxonomy in the identication of
compound class was further highlighted in this recentThis journal is © The Royal Society of Chemistry 2021contribution110 by Rutz et al. where the authors present an open
natural products database LOTUS (naturaL prOducTs occUr-
rences databaSe) in which the biological occurrences of over
500 000 natural product metabolites collected from various
sources111,112 are now extensively documented.7 Other analytical methods
Although NMR and MS are two major workhorses for mixture
analysis these days, other spectroscopic methods are also
occasionally used for class or substructural annotation of
metabolites. For example, using a photodiode array detector
(PDA), ultraviolet and visible wavelength (UV-VIS) absorption
spectra can be obtained that have been used for rough class
annotation of chromophores for decades, and are still used for
identication of specic molecular classes, or identication of
metabolites in specic taxa; e.g. avonoids in plants113 or
phenolic compounds in lichens.114 This knowledge is generally
applied by manual inspection, but a recent study on avonoid
analysis demonstrated that UV-VIS-based annotations also can
be computionalized.115 Vibrational spectroscopic methods,
such as near infrared (NIR), Fourier transformed infrared (FTIR)
and Raman spectroscopy, have their own advantages; they can
provide rapid, high-throughput, and non-destructive analysis.
Vibrational spectroscopic methods provide highly overlapped
signals frommultiple molecules, so they are typically applied as
“ngerprint” methods rather than to structurally identify indi-
vidual constituents. However, if they provide fundamental
information about the presence of functional groups in mole-
cules, they have enough potential to be applied to substructural
identication in the metabolomics workow, especially of
active groups that are oen crucial for bioactive or toxic prop-
erties of a molecule. Recently, the combined input of FTIR and
MS spectra was used to train a deep learning model to recognize
the presence of functional groups such as carboxylic acid,
aromaticity, and the ester group.116 The authors concluded that
FTIR spectra could in many cases reliably annotate such func-
tional groups, but MS did offer additional information in a fair
number of cases. In another recent example, infrared ion
spectroscopy linked to mass spectrometry could readily sepa-
rate enantiomeric N-acetylhexosamines identied in body uid
samples.117,118 As typical natural mixtures contain numerous
isomeric molecules, infrared ion spectroscopy is expected to be
of great added value for molecular identication.8 The future of computational
metabolomics in natural products
discovery
8.1 Toward a database of annotated structural motifs
The various examples provided here make clear that over the
last two decades enormous steps have been taken in metab-
olomics analyses to go from le-by-le analysis toward inte-
grated multi-le analyses of entire experiments. Several parts of
the metabolomics analysis workow have been automated
effectively such as preprocessing and noise ltering. However,Nat. Prod. Rep.
























































































View Article Onlinemetabolite feature recognition and metabolite annotation and
identication remain bottlenecks as they still require substan-
tial manual intervention and expertise. We argue here that
machine learning approaches and network and substructure-
based approaches are key strategies to come to the higher
level of automated analysis needed to enable larger-scale
metabolomics analysis compatible with the information-dense
spectral data that current and the future instrumental
advances will bring. Machine learning approaches could be
used to more accurately detect metabolite features in mass
spectrometry and especially NMR data. The automated recog-
nition of signals in 2D-NMR spectra is far from a solved chal-
lenge and with the increasingly available annotated datasets
that will provide sufficient training and test material, the
manual process of signal recognition could be automated. It is
interesting to note that there is currently no central server to
upload NMR spectra, and process, analyze, and visualize NMR
results supported by a public spectral library,119 whilst several of
such platforms have emerged for mass spectrometry-based
metabolomics data.21,120,121 We do note that initiatives like
nmrML122 and NMReDATA123 have been proposed which we
believe will in turn spark the development of computational
NMR-based metabolomics tools.
Inmass spectrometry, the better discrimination between real
metabolite features and artefact signals remains a topic of
much attention and debate, with ion identity networking as one
of the latest approaches to declutter the complex and dense
mass spectral datasets.124 Aer establishing a good peak list, the
challenging structural annotation step begins. Here, the more
efficient mining for unique substructure motifs will facilitate (i)
the prioritization of novel chemistry in complex metabolite
mixtures, and (ii) the structural elucidation procedure as such
substructure motifs can oen be related to biosynthetic or
chemical building blocks of the metabolites. In mass spec-
trometry, tools like MS2LDA16 and MESSAR23 have started to
recognize substructure motifs based on spectral data, and
MotifDB20 is able to store annotated substructure motifs facili-
tating their reuse for future structural annotation purposes;
however, in many cases, the structural annotation and veri-
cation of the substructure chemistry still relies on analytical
experts that need to identify the structural motifs by linking
them to elemental formulas and structures or chemical
compound classes. In NMR, 2D-NMR spectra have started to be
exploited to recognize substructure motifs,125 but here the
automated recognition of NMR signals may hamper progress in
this area. Looking into the future, we can envision the imple-
mentation of a database of MS and NMR annotated substruc-
ture motifs that can be used to populate the majority of
metabolite features in your experiments with structural infor-
mation supporting larger-scale metabolomics analyses (Fig. 5).8.2 The integration of LC-MS/MS and 2D-NMR approaches
The remarkable increase in available computational metab-
olomics workows has boosted many scientic disciplines that
rely on small molecule measurements; however, it has also
come with new challenges. In order to combine the analysis ofNat. Prod. Rep.mass spectral and NMR-based experiments, the output of
various tools needs to be combined. This is far from trivial, even
within these two analytical elds, as was demonstrated by the
development of MolNetEnhancer36 that brings together the
output of various metabolome mining and annotation tools,
thereby also facilitating the structural annotation of substruc-
ture motifs. We note that the various input and output formats
that exist can hamper integrated analyses with the risk of
creating “analysis silos” that on itself are great data analysis
ecosystems but their output is hard to effectively combine with
other tools. A possible solution is to make such tools compat-
ible with the various ecosystems; however, this puts a substan-
tial additional burden on the tool developers.
Existing approaches that combine LC-MS/MS and 2D-NMR
analysis typically perform the analytical analyses separately
for each platform and then combine that knowledge manually
during the structural elucidation process,126 or select candidates
based on onemethod and then further reduce that list using the
other method,127 for example by annotating relevant substruc-
tures from LC-MS/MS data or MSn data128 and look for them in
the NMR data.125 To perform simultaneously integrated LC-MS/
MS and 2D-NMR analyses, the initial – very different – spectral
data needs to be converted into a list of metabolite features with
spectral and substructure properties that can be compared
across and linked. We foresee a possible route by doing mixture
analysis and applying (2D-)NMR and LC-MS/MS on the same
samples and then combine and link the output of MS2LDA and
MADByTe or the approach described by Kuhn et al.125 where
prediction of 2D-NMR signals is used but then focused on the
recognition of substructure motifs. Instead of rst extracting
substructure information from one method and then doing
a targeted search to nd them back in the other method, such
an approach would enable increased crosstalk between MS and
NMR through substructure linking. It has to be noted that the
availability of the necessary equipment to perform both MS and
NMR based analyses may hamper the uptake of such an inte-
grated approach, as well as the costs to run and maintain such
platforms or to outsource the measurements. Finally, to train
algorithms in the effective linking of substructure data obtained
from MS/MS and 2D-NMR, there is a need for the increased
availability of well-curated datasets of complex mixtures with
known constituents. Nevertheless, we foresee that such an
approach can become very powerful in prioritizing novel
chemistry and accelerating its structural elucidation, especially
if supported by a database of annotated substructure motifs as
discussed above.8.3 Pathway and taxonomy supported metabolite annotation
Metabolites are seldomly present in isolation in complex
mixtures, as they are typically linked to other metabolites
through shared biochemical pathways or building blocks. To
make effective use hereof, it is important to consider the
biosynthetic capabilities of the organisms present in your
experiment. For example, the concept of taxonomically
informed scoring makes use of the presence and absence of
metabolites across species and genera, thereby rerankingThis journal is © The Royal Society of Chemistry 2021
Fig. 5 Technical advances on both the MS and NMR side both result in unprecedented chemical insights in complex metabolite mixtures. The
recent surge in available computational metabolomics tools to extract substructure and chemical class information and to build networks based
on spectral data is remarkable. Looking into the nearby future, we foresee an increased demand to perform large-scale repository-wide
metabolomics analyses and the establishment of a database focused on substructuremotifs that can be recognized in MS (MS/MS) and NMR (2D-
NMR) data will be a key pillar to do so to annotate all the key building blocks in complex mixtures that form the bioactive components. Here, we
recognize that the MS field has started to organize itself over the last years with centralized repositories and analysis workflows for processing,
comparison, and visualization, whereas in the NMR field this is still largely absent, although there are some encouraging signs based on recent
literature. Furthermore, this will also highlight the opportunities for crosstalk between those two analytical routes. We note that both chemical
class assignments and network analysis can be used on their own to perform large-scale analyses as well. We also note how complementary
information, for example from genomics analyses where genome mining tools are predicting structural features with increasing accuracy, will
further help in structural annotation of complex chemical mixtures. This will work especially well in tandem with well-curated taxonomic
resources, a field in which we observe increasing efforts lately. This will not only provide organism-tailored candidate metabolite lists for omics
experiments, but also complement the information from genome mining and allow researchers to further fill in the gaps in the specialized
metabolomes of organisms. Ultimately, we believe that the here described tools and our perspective on their future developments will altogether
transform metabolomics datasets from collections of spectral features to biochemical interpretable representations.
























































































View Article Onlinecandidate structure lists.63 The whole idea of chemotaxonomy
arises from the necessity for a living organism to produce a set
of compounds linked to its gene pool. We thus believe the
recent development of the well-curated compound databases
NP Atlas129 for microbial metabolites and LOTUS110 for (mainly)
plant-based metabolites are essential for the well-functioning of
such approaches. The concept of metabolite consistency130 then
uses the knowledge of known biochemical pathways to assign
the most likely candidate structure by eliminating theoretical
options that do not t with reported enzymatic activity. Pathway
analysis is used to extract possible active pathways, oen in
combination with comparative metabolomics (see Section 8.4)
based on known biochemical pathways or based on prediction
of their presence. For example, NICEpath uses the concept ofThis journal is © The Royal Society of Chemistry 2021conserved atom ratio to detect plausible reaction pathways in
large biochemical networks,131 and PALS decomposes known
metabolic pathways that could be present in the samples or
metabolite sets representing possible pathways by using
metabolomics data from various conditions.132 An important
limitation of the above strategies is the bias most of these
approaches will have toward what we already know, as it is very
challenging to acknowledge unexpected biochemical trans-
formations through such strategies. In that sense, the concept
of differentially expressed metabolite sets (as enabled by PALS)
that contain metabolites grouped based on their spectral
similarity is an interesting exception; however, such metabolite
sets do not necessarily represent biochemical pathways and
further validation steps are thus required.Nat. Prod. Rep.
























































































View Article Online8.4 Comparative metabolomics and metabolite annotation
Comparative metabolomics typically aims to detect differences
in metabolite proles between samples or differential condi-
tions. Essential parts of such a workow are the peak picking of
MS or NMR metabolite features in all samples and the align-
ment of the same metabolite features across all samples to
enable the statistical comparison based on peak heights or
areas of metabolite features. Following such an approach,
metabolite features can be linked to certain phenotypes, activ-
ities, or functions, and thus prioritized for further analyses,
oen including their structural elucidation. Recently, the
concept of comparative mass spectrometry-based metab-
olomics was seamlessly integrated with molecular networking
resulting in Feature-Based Molecular Networking (FBMN).133
Following this analysis workow enables the more accurate
detection of isomers in molecular networks, and the use of
reliable quantitative values for metabolite feature abundance.
This in turn allows for interesting future applications such as
the complementary use of correlation-based network edges in
the molecular network that connect nodes that “behave simi-
larly” across the sample types investigated. When combined
with substructure-based workows, a similar workow could
yield metabolite substructures that are enriched in particular
sample types or correlated to a specic bioactivity based on
their presence and absence across many phenotyped samples.
Very recently, Qemistree was introduced that allows the
comparison of MS/MS-based metabolite proles in a chemi-
cally-informed manner.43 Ideally, when comparing metabolite
proles, one would like to acknowledge that samples that
contain a high proportion of similar chemistry (i.e., avonoid
glycosides), but not many completely identical components, are
still more related than samples that contain different chemistry
altogether (i.e., avonoids versus terpenes). To achieve this,
molecular structure ngerprints were rst predicted from the
MS/MS spectra using SIRIUS-CSI:FingerID,27 followed by their
comparison through hierarchical analysis that results in a tree
akin to when analyzing and visualizing the relatedness of DNA
sequences. Here, metabolite features with similar molecular
ngerprints end up close together in the phenetic tree. When
performed on a metabolomics experiment and decorated with
sample metadata and chemical ontologies, this allows to gain
insights in sample relatedness through the relatedness of their
individual constituents. Similar approaches for NMR-based
metabolomics experiments are expected to provide similar
advantages, especially when the computational workows that
support large-scale analyses will further mature.8.5 Structural diversity and the limitations of spectrum-
based analysis
Whilst many powerful tools and examples were provided in this
review, spectrum-based analyses have their limitations. In mass
spectrometry, the MS/MS fragmentation that many tools now
heavily rely on for structural information happens in the gas-
phase in collision cells of mass spectrometers. As a matter of
fact, and despite some successes,25 not much is understood
from gas-phase chemistry and predicting when and howNat. Prod. Rep.metabolites fragment remains very challenging, especially for
electrospray ionization (ESI)-based collision induced dissocia-
tion (CID) types of fragmentation. In NMR, the complexity of
2D-NMR spectra with lots of overlap make it challenging to
automate peak-picking and there is quite a sensitivity gap with
mass spectrometry.
Furthermore, chemically divergent yet very relevant
compound classes like alkaloids and terpenoids pose inter-
esting questions in relation to network and substructure-based
approaches: how to comprehend these chemical compound
classes from a substructure/chemical class point of view?
Historically, the different biosynthesis routes have determined
various subclasses of alkaloids and terpenoids, but these are
not always easily recognized by spectral features as sometimes
a tiny structural difference is hardly visible in the analytical data
but needs a substantially different enzymatic route, or vice versa:
a tiny structural difference due to the decoration of a scaffold
causes drastic changes in the spectra.128 Such situations are
difficult to resolve and may signpost the border area of where
spectral-based analyses are useful. However, with the increase
of publicly available data and the development of novel tools
such as the new mass spectral similarity measure Spec2Vec as
well as alternative networking-based approaches,45,134,135 it could
well be possible to group together structurally similar metabo-
lites (according to historical reasons and/or biosynthetic routes)
taking into account that mass spectral features that are not
exactly similar could still be related to each other. Moreover,
with an increased number of annotated datasets, supervised
machine learning approaches could further improve on the
current performance of Spec2Vec.8.6 Breaking barriers
Another route to improve on metabolite annotation perfor-
mance is to gain complementary information about the same
samples from other sources such as genomics. In natural
product discovery, genome mining tools such as antiSMASH136
can mine genome and metagenome sequences for their
biosynthesis potential and return predicted biosynthesis gene
clusters that likely encode for the production of specialized
metabolites. Tools like BiG-SCAPE137 and BiG-SLICE6 can, at
a respectively smaller and larger scale, group those biosynthesis
gene clusters in gene cluster families that are likely to produce
structurally related metabolites. One can then envision that
such gene cluster families could be linked to molecular families
obtained from metabolomics data,138 for example through
pattern-based genome mining.139 That would help to nd the
likely producers of specialized metabolites in complex samples,
as well as to gain complementary structural information such as
about the stereochemistry of chiral centers. In recent years, the
rst strain correlation and feature-based scores have been
developed,15 as well as novel scores,140 i.e. as proposed by Sol-
datou et al.,141 to charter chemical diversity in polar bacteria.
Such attempts are largery enabled by cataloguing (i) known and
validated biosynthesis gene clusters (BGCs) encoding for the
production of specialized metabolites in MIBiG,142 (ii) known
and curated metabolites with metadata on their origins inThis journal is © The Royal Society of Chemistry 2021
























































































View Article Onlinedatabases such as NP Atlas,129 and reference spectra in open
libraries such as those from MassBank143 and GNPS,21 and will
be further driven by their integration and initiatives such as the
paired omics data platform that brings together sequenced
genomes and metagenomes with LC-MS/MS metabolomics
proles that are available in the public domain.144 For example,
the NPLinker framework has already adopted a workow to
directly read in data from the paired omics data platform to
then perform various scores to rank and prioritize BGC-MS/MS
spectral links for further study.140 Looking into the future,
substructure-based workows could further enhance such
rankings by linking the substructure annotations of MS2LDA
and MESSAR with those from the antiSMASH subclusterblast
and by statistical recognition of genes that could encode for the
production of a substructure.145 Alternatively, the predicted
antiSMASH compound classes (non-ribosomal peptides, poly-
ketides, etc.) could be used to prioritize MS or NMR spectra that
are predicted to be of those compound classes through the use
of MolNetEnhancer or CANOPUS or NMR-based alternatives.
Most of the attention in this review was spent on the
proling of non-volatile specialized metabolites. However,
nature produces many volatiles and recently an open platform
for GC-MS data analysis and library matching was established.54
Analogous to the above-described options to link MS/MS-based
substructures with those observed in 2D-NMR, we could envi-
sion something similar for GC-MS to develop.
The structural annotation of metabolites is usually only the
start: it is typically the functional annotation that is most rele-
vant to the biological or biochemical research question. Well
curated and annotated datasets are crucial to make large-scale
metabolomics analyses effective in functional analysis. In that
respect, the launch of ReDU in 2020 symbolizes the beginning
of repository-level analysis of MS/MS datasets.146 ReDU allows
the reanalysis of public MS/MS datasets with metadata using
a controlled vocabulary, which enables researchers to project
their data on all the available public data in ReDU and assess its
chemical uniqueness. The other way around, researchers can
also select a specic subset of the LC-MS/MS data, for example
all fungal datasets, when they want to study fungal chemical
diversity. The next step is to do the same thing for MS/MS
spectra: when metadata at the spectral level is consistently
collected and stored, this will allow researchers to better track
the origin and possible functions of the metabolites in their
proles. Moreover, through network and substructure-based
approaches, such spectral metadata can also be propagated to
related metabolites in the same dataset. It is encouraging to
observe that also on the NMR side there is an increased atten-
tion for sample metadata.147
With analyses happening at increasingly larger scales, in-
depth repository-scale analyses are becoming within reach. To
visualize such amounts of data and efficiently extract the rele-
vant information from it, novel algorithms are needed that are
scalable, i.e., in clustering all MS/MS spectra, that speed up
analysis time, and that can visualize the resulting data struc-
tures to enable analysis and biochemical interpretations. Such
developments that lead toward repository-scale analyses will in
turn increase the benets of sharing well-documented datasetsThis journal is © The Royal Society of Chemistry 2021in the public domain, thus changing data sharing from
a perceived (time) burden into an actual benet.
We do note that the growth in the number of available
computational tools and the increasing density and size
(number of data les) of typical metabolomics experiments can
come with high computational costs. Whilst numerous tools
can be run on a fairly normal laptop or desktop computer, there
are several tools that benet from dedicated servers with suffi-
cient memory and cores available. Furthermore, many tools
have not been fully optimized for performance; we refer to the
review by Chang et al. for an extensive overview of these and
other opportunities and limitations of current metabolomics
tools.148 It is encouraging to see that platforms such as GNPS21
put effort in integrating novel workows (many of which high-
lighted in this review) into their workows. This not only makes
them easier to integrate in metabolomics analysis, but also
democratizes their use as the users can also access dedicated
analysis servers linked to GNPS that they otherwise may not
have had access to. We expect that with increased popularity of
the described approaches, more of such analysis services are
likely to appear.
9 Conclusions & final perspectives
Computational metabolomics approaches have started to
change the metabolomics eld by automating various aspects of
typical metabolomics workows and thereby enabling large-
scale metabolomics analysis. Together with the current
increase in publicly available datasets, this has also shied the
focus of many studies towards unknown metabolites that are
not fully described and catalogued in databases yet. In this
paper, we show how substructure and network-based metab-
olomics approaches can cause a paradigm shi in the annota-
tion level of these yet unknown metabolites in the forthcoming
years by leveraging structural, chemical compound class, and
substructural information from MS/MS and NMR spectral data.
Once structural motif databases are sufficiently populated, they
in turn will spark the development of new tools to accelerate the
elucidation of entire structures and metabolic pathways based
on the available spectral data in various conditions. We expect
that the linking of MS/MS spectra to information obtained from
genome mining positively contributes to the annotation power
of metabolomics data. We foresee that the impact of machine
learning-based approaches will further increase with the
increased availability of metabolomics data that can serve as
training and test data to improve the performance of spectral
library matching and to create biochemically interpretable mass
spectral networks. Together with well-curated and consistent
reported metadata, this will open up new avenues to directly
link taxonomic and functional annotations to spectral data.
Altogether, we conclude that networking and substructure-
based computational metabolomics analysis workows have
already started to form an essential part of the future of
metabolomics in which large-scale metabolomics datasets can
be rapidly transformed into present and active metabolic
pathways and metabolite groups with annotated functions –
a necessity to efficiently apply wide-screen metabolomicsNat. Prod. Rep.
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A. K. Jarmusch, A. M. Caraballo-Rodŕıguez, K. Weldon,
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